Infective endocarditis (IE) continues to be an important medical issue. The incidence of IE ranges from 3 to 10 episodes/100 000 person-years, and the risk of developing IE increases dramatically with age (14.5 episodes/100 000 person-years for patients aged 70-80 years). 1, 2 Over the past 30 years, neither the incidence nor the associated mortality has decreased, despite major advances in both diagnostic and therapeutic procedures. New predisposing factors have been identified, such as valve prostheses, degenerative valve sclerosis, and intravenous drug abuse.
otherwise both TTE and TEE are limited by their dependence on the individual patient's morphology, instrumental settings, transducer position, operator, and artefacts from heavy valve calcifications and metallic prosthetic valves through acoustic shadowing. Therefore, if an initial echocardiography is negative, repeated TEE examinations are recommended in cases of clinical suspicion. 5, 6 The question of whether performing TTE prior to TEE is necessary in the evaluation of suspected prosthetic valve vegetations is a difficult one. Guidelines provided by the American Heart Association, American College of Cardiology, and American Society of Echocardiography in 2003, 7 stated that sequential examinations starting with TTE is the preferred approach given the essential information on cardiac function and haemodynamics provided by TTE. However, particularly in the case of PVE, protocols in which TTE is ordered first may subject patients to unnecessary delays in diagnosis as well as increased overall costs, and also the results of this test are more frequently negative for PVE. 8 18-Fluoro-2-deoxyglucose positron emission tomographycomputed tomography ( 18 F-FDG-PET-CT) (fluorodeoxyglucose labelled with fluorine-18) is a well-recognized imaging tool that is most often used in oncology, but also in infectious diseases, vasculitis, cardiology, and neurology disorders; 9-12 increased levels of glucose are detected in granulocytes and monocytes. Emerging data suggest a role for 18 F-FDG-PET-CT in the diagnosis of endocarditis and endovascular graft and pacing system infections when conventional diagnostic tools have failed.
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The aim of this study was to evaluate the diagnostic efficacy of 18 F-FDG-PET-CT in native valve endocarditis (NVE) and PVE in a group of patients referred to our department with a suspicion of IE during the period 2008-2013.
Methods

Patients
Between January 2008 and October 2013, 27 consecutive patients were admitted to the Infectious Disease Department with a suspicion of IE. On admission, the evaluation of possible and definite IE cases was based on the clinical and/or pathological modified Duke criteria. 3 The final IE diagnosis was defined according to the modified Duke criteria and the microbiological and diagnostic results collected from each patient. The assessment of individual cases on the basis of the above criteria allowed us to confirm or reject the diagnosis of IE. All of the patients underwent physical examinations, laboratory investigations, culture tests, and additional diagnostic procedures, including chest X-ray, abdominal ultrasound, and TTE. As a result of technical problems, intolerance, or patient refusal, TEE examination was limited to only 11 patients. All of the accepted patients underwent 18 F-FDG-PET-CT at admission, a median of 4 days (range 3-8 days) after the start of antibiotic therapy. 18 F-FDG-PET-CT was used as an additional tool to confirm the diagnosis of IE, to evaluate peri-valve extensions and early peripheral embolisms, or to rule out other infectious foci, and was never used alone to assess the clinical management of the patients.
Late PVE was defined as an infection that presented at >12 months after heart surgery, and early PVE as an infection that presented at <12 months after surgery.
Demographic, clinical, microbiological, and treatment data were collected retrospectively. The ethics committee of Tor Vergata University Hospital approved this study.
2.2.
F-FDG-PET-CT
All patients underwent 18 F-FDG-PET-CT in the resting state after eating a meal rich in fat and low in carbohydrates to reduce the physiological uptake of FDG in the myocardium. 17 The test was performed after a 6-h fasting period. Glycaemia was determined to be 120 mg/dl at the time of the study. One hour after the intravenous injection of 4 MBq/kg 18 F-FDG, a low-dose wholebody CT scan from the mid-thigh to the vertex was acquired using a Discovery VCT PET/CT (GE Healthcare, Milwaukee, WI, USA). Once the CT imaging was completed, PET acquisition was performed in the three-dimensional mode, and the data were reconstructed using the iterative method (algorithm OSEM); the CT data were used for attenuation correction.
Interpretation of 18 F-FDG-PET-CT
The cardiac images were interpreted independently by two nuclear medicine physicians who were blinded to the clinical data and other imaging studies. In two cases where the two physicians disagreed on a diagnosis, consensus was reached via a third physician. In patients with suspected NVE, any increase in FDG uptake in or around the heart valves outside the myocardium was considered abnormal. In patients with suspected PVE, the analysis was performed on both the attenuation-corrected and nonattenuation-corrected images, and the presence of hotspots in the prosthetic and periprosthetic areas was considered abnormal (Figures 1 and 2 ).
Statistical analysis
This should be considered a retrospective and observational study. Continuous variables are expressed as the mean value. Categorical data are expressed as numbers with percentages. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated using the final diagnoses of confirmed NVE or PVE and the rejected NVE or PVE as the outcomes. The sensitivity, specificity, NPV, and PPV of the Duke criteria, echocardiography (TTE and TEE), and 18 F-FDG-PET-CT were calculated based on the final diagnosis of IE using SPSS 16.0 software (SPSS Inc., Chicago, IL, USA). All of the tests were twosided. A p-value of <0.05 was considered significant. Table 1 shows the characteristics of the 27 patients enrolled in the study, 20 of whom had a prosthetic valve and seven of whom had a native valve. The majority of the patients were men (74%, 20/ 27), and the mean age was 63 years (range 41-83 years). At the final evaluation, the IE diagnosis was confirmed in 25 of the 27 patients (92%), and these patients were treated with a standard course of antibiotics in accordance with international guidelines. 1, 2 In two cases (patients 17 and 18) with a possible IE diagnosis according to the modified Duke criteria at admission, the final IE diagnosis was rejected. Of the 25 patients with a confirmed IE final diagnosis, 18 (72%) had PVE (16 aortic and two mitral prosthetic valves). Eight patients (44.4%) had an early infection, with a mean time to onset from surgery of 5 months, whereas 10 patients (55.5%) had a late infection, with a mean time to onset from surgery of 12 months. Seven (28%) out of 25 patients had NVE.
Results
All 20 PVE patients underwent TTE at the initial diagnostic evaluation and only nine patients were subsequently evaluated by TEE. In five out of 11 patients (patients 10, 12, 14, 16, and 19) not evaluated with TEE, the TTE resulted positive for IE; the remaining six patients refused or did not tolerate the examination. Five of these (patients 1, 3, 4, 7, and 20) were confirmed with IE at the final evaluation and were treated successfully with antibiotics according to the procedures and time limits established in international guidelines. For the sixth patient (patient 18), the diagnosis of IE was rejected.
Only two out of nine patients who underwent TEE (patients 9 and 15) the exam provide additional diagnostic information to TTE. Seven out of the nine patients with positive TEE findings also had a positive 18 F-FDG-PET-CT result and had a confirmed IE diagnosis at the final evaluation. The other two patients, one with a positive and one with a negative TEE evaluation, had negative 18 F-FDG-PET-CT results. The last patient (patient 17) had a rejected IE final diagnosis. All patients with NVE had evidence of vegetations on TTE; TEE was done in only two cases, which confirmed TTE findings. Due to persistent infections despite antibiotic treatment, valve replacements were needed in seven cases (four with PVE and three with NVE), and a valvuloplasty was needed in one case. A prolonged antibiotic course (6-12 months) was needed for 10 PVE cases in whom prosthetic valve replacement was not possible due to the high surgical risk. Valve infections were confirmed by biopsy' in two cases (patient 6 Enterococcus faecalis, and patient 10 Candida parapsilosis).
There were four in-hospital deaths (14%) due to complications of sepsis (Table 1 ; patients 1, 11, 16, and 24). The remaining 21 patients were treated successfully and were considered infectionfree when screened at the scheduled follow-up.
The main presenting symptoms of suspected IE were fever of unknown origin (17/27, 62%), bacteraemia or sepsis (5/27, 18%), major vascular phenomena (3/27, 11%), vegetations (10/27, 37%), valvular or perivalvular damage (3/27, 11%) as determined by TTE, and dyspnoea and chest pain in one case.
In the 25 cases of confirmed IE, the causative microorganisms were coagulase-negative staphylococci in four cases, Enterococcus faecalis in six cases, Streptococcus viridans in four cases, Candida parapsilosis in two cases, methicillin-sensitive Staphylococcus aureus (MSSA) in two cases, Pseudomonas aeruginosa in two cases, methicillin-resistant S. aureus with reduced susceptibility to vancomycin (hetero-VISA) in one case, Streptococcus bovis in one case, and Enterococcus spp in one case (organism identified through molecular testing). Four patients had culture-negative IE; these patients were taking antibiotics at the time of clinical evaluation and tested negative for Coxiella burnetii serology (data not shown). Table 2 shows a comparison of the revised Duke criteria evaluations, TTE or TEE echocardiogram findings, and 18 F-FDG-PET-CT scan results. The comparison of the different methods was conducted on only 22 out of the 27 subjects studied, considering only PVE patients with positive echocardiography evaluations and ruling out patients without a TEE evaluation. In this table, the sensitivity, specificity, PPV, and NPV for the overall studied patients (section A) and separately for the 15 patients with suspected PVE (section B) and the seven patients with NVE (section C) were reported according to the final diagnosis of confirmed or rejected IE. In section A, according to the Duke criteria, only two patients with possible IE were not confirmed at the final evaluation (sensitivity 70%, specificity 100%, PPV 100%, and NPV 25%). At the echocardiography (TTE or TEE) evaluation, 16 out of 20 patients with confirmed IE had positive findings (sensitivity 80%, specificity 100%, PPV 100%, and NPV 33%). Finally, 11 out of 20 patients with a confirmed IE final diagnosis had positive 18 F-FDG-PET-CT results (sensitivity 55%, specificity 100%, PPV 100%, and NPV 18%). The diagnostic tool with the greatest sensitivity in detecting IE in the total studied population was echocardiography (80% vs. 70% for the revised Duke criteria and vs. 55% for 18 F-FDG-PET-CT).
In section B, 13 out of 15 patients with suspected PVE had a confirmed IE final diagnosis. Four of these patients had negative echocardiography results, and two of these patients had negative 18 F-FDG-PET-CT results.
18 F-FDG-PET-CT showed a sensitivity of 85% (vs. 69% for echocardiography and 77% for the revised Duke criteria). A greater number of patients with PVE had positive 18 F-FDG-PET-CT results compared to those with positive echocardiography findings (11/13 vs. 9/13).
In section C, all seven patients with NVE had positive echocardiography and negative 18 F-FDG-PET-CT findings (p < 0.001). The echocardiography findings had a sensitivity of 100% (vs. 57% for the revised Duke criteria).
Discussion
In this retrospective study of patients with suspected IE, echocardiography was shown to have the highest sensitivity (80%) as a diagnostic tool in evaluating the overall population. The ability to rule out infection (NPV) was low for all of the diagnostic tools used (18-33%), and 18 F-FDG-PET-CT did not provide any additional diagnostic value to the revised Duke criteria. However, when patients with PVE and NVE were analysed separately, several interesting results emerged. 18 F-FDG-PET-CT was the most effective tool at diagnosing PVE, with a sensitivity of 85% and an NPV of 50% when evaluated against the results obtained by echocardiography. In addition, 89% overall of confirmed PVE had a positive 18 F-FDG-PET-CT result. The revised Duke criteria and echocardiography findings showed good, although reduced compared to 18 F-FDG-PET-CT, sensitivity for PVE (77% and 69%, respectively), but a poor ability to rule out the diagnosis (NPV 28% and 25%, respectively). The situation was completely reversed in patients with NVE: 18 F-FDG-PET-CT failed to detect the infection in all cases, demonstrating that this tool is not appropriate for establishing or ruling out infection of native cardiac valves. Recent guidelines have highlighted how echocardiography findings and microbiology results can be inconclusive in patients with cardiac devices or valvular prostheses. (32/42) of the infected device cases compared to the lack of uptake in six control patients. 25 In a more recent paper, Erba et al. Additionally, hyperglycaemia may interfere with this process and can lead to false-negative results. In our study, these reasons do not explain the negative 18 F-FDG-PET-CT scans in patients with NVE.
More likely, as some authors have suggested, the 18 F-FDG-PET-CT scans do not show vegetations that are normally seen by TTE/TEE; rather, 18 F-FDG-PET-CT shows valvular and perivalvular infections indicative of infectious processes or small abscesses at the valvular position, which are more easily detectable in the case of prosthetic infections. 18 False-positive scans may also occur in patients with recently implanted vascular devices. 19 In our study, eight patients had early PVE, which occurred less than 12 months after surgery (mean 5 months, range 3-9 months). All of these patients had confirmed IE on the basis of positive blood cultures for a typical microorganism and positive 18 F-FDG-PET-CT results at the site of engraftment, without any other possible sources of infection. Several studies have evaluated the role of 18 F-FDG-PET-CT in the diagnosis of focal infections or inflammatory diseases in critically and non-critically ill patients, and have found a NPV of nearly 100%, thus concluding that negative 18 F-FDG-PET-CT scans almost certainly appear to exclude focal infections as a cause of clinical symptoms. 12 Moreover, a recent extensive study described the excellent sensitivity and anatomical precision of 18 F-FDG-PET-CT for the early detection of embolisms and metastatic infections secondary to IE. 18 In our study population, 18 F-FDG-PET-CT also demonstrated peripheral embolism (cerebral, splenic, and intestinal) in six cases (five PVE and one NVE) (data not shown). Before drawing conclusions, some limitations of our study must be discussed. First, the small number of patients studied does not provide sufficient strength for the routine use of 18 F-FDG-PET-CT for PVE diagnosis. Second, we evaluated cases of IE admitted consecutively to our infectious diseases ward, coming from other wards of the hospital in which the suspected diagnosis was based on the modified Duke criteria. This could be considered a bias of our study, as we enrolled consecutive patients with a strong suspicion of IE and this explains the very low number of patients for whom the IE diagnosis was rejected. Otherwise, taking into account the limitations mentioned above, the results of the present study suggest the potential advantage of 18 F-FDG-PET-CT in the diagnosis of IE in patients with prosthetic cardiac valves, particularly in cases in whom negative echocardiography findings or negative blood cultures make a defined IE diagnosis difficult.
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